News|Articles|April 2, 2025

Nephrology Month in Review: March 2025

Name: Expert Perspectives: Iptacopan FDA Approval for C3 Glomerulopathy
Uploaded: 2025-04-02T10:00:00Z
Duration: 3 min 11 s
Description: Expert Perspectives: Iptacopan FDA Approval for C3 Glomerulopathy

Author(s)Abigail Brooks, MA

Fact checked by: Ryan Livingston

The March 2025 month in review spotlights a new episode of Crisis Point about CKD for National Kidney Month and renal FDA news.

March was a significant month for the field of nephrology, characterized by key US Food and Drug Administration (FDA) decisions and broader recognition of the growing chronic kidney disease (CKD) crisis.